Denosumab for the treatment of bone disease in solid tumors and multiple myeloma
Author:
Affiliation:
1. Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
2. Harvard Medical School, Boston, MA 02114, USA
Abstract
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon-2017-0403
Reference59 articles.
1. Novel Bone-Targeted Strategies in Oncology
2. Osteoclast differentiation and activation
3. Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
4. Breast Cancer Increases Osteoclastogenesis by Secreting M-CSF and Upregulating RANKL in Stromal Cells
5. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model;European Journal of Medical Research;2023-10-13
2. Evaluación económica de denosumab en pacientes con tumores sólidos con metástasis óseas en el IMSS;Gaceta Mexicana de Oncolog�a;2023-06-30
3. Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy Monitoring: a Denosumab Experience;Laboratory Medicine;2022-10-12
4. Biological and Clinical Aspects of Metastatic Spinal Tumors;Cancers;2022-09-22
5. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications;Cells;2022-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3